- Corporate Officers - R
- Rhoads Ann D
Insider Trading History of Rhoads Ann D
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Rhoads Ann D since 2020.
This trader's CIK number is 1250252.
At the time of last reporting, Rhoads Ann D was the Director of Quidelortho Corp. (stock ticker symbol QDEL).
Also see all insider trading activities at Quidelortho Corp.
Note that in the past
RHOADS ANN D also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Quidel Corp /de/ (QDEL) by Rhoads Ann D
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | QDEL | 0 | $0 | 0 | $0 | 1,624 | $0 |
| 2021 | QDEL | 0 | $0 | 0 | $0 | 624 | $0 |
Yearly summary of insider trading at Quidelortho Corp (QDEL) by Rhoads Ann D
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | QDEL | 750 | $21,206 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Repare Therapeutics Inc. (RPTX) by Rhoads Ann D
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | RPTX | 4,000 | $80,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Forty Seven, Inc. (FTSV) by Rhoads Ann D
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | FTSV | 0 | $0 | 1,924 | $183,597 | 20,950 | $183,480 |
Yearly summary of insider trading at Globus Medical Inc (GMED) by Rhoads Ann D
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | GMED | 0 | $0 | 20,000 | $1,402,600 | 0 | $0 |
| 2024 | GMED | 0 | $0 | 15,000 | $1,055,400 | 35,000 | $868,350 |
| 2023 | GMED | 0 | $0 | 0 | $0 | 7,500 | $94,425 |
| 2021 | GMED | 0 | $0 | 0 | $0 | 15,384 | $163,993 |
Insider trading activities at 5 companies by Rhoads Ann D:
1. Quidel Corp /de/ (QDEL)
2. Quidelortho Corp (QDEL)
3. Repare Therapeutics Inc. (RPTX)
4. Forty Seven, Inc. (FTSV)
5. Globus Medical Inc (GMED)
Table 1. Insider trading of Quidel Corp /de/ (QDEL) by Rhoads Ann D
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-05-18 | QDEL | Option Ex | 1,624 | .00 | 0 |
| 2021-05-12 | QDEL | Option Ex | 624 | .00 | 0 |
Table 2. Insider trading of Quidelortho Corp (QDEL) by Rhoads Ann D
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-12-10 | QDEL | Buy | 750 | 28.27 | 21,206 |
Table 3. Insider trading of Repare Therapeutics Inc. (RPTX) by Rhoads Ann D
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-06-23 | RPTX | Buy | 4,000 | 20.00 | 80,000 |
Table 4. Insider trading of Forty Seven, Inc. (FTSV) by Rhoads Ann D
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-04-01 | FTSV | Option Ex | 20,950 | 8.76 | 183,480 |
| 2020-04-01 | FTSV | Sale | 1,924 | 95.42 | 183,597 |
Table 5. Insider trading of Globus Medical Inc (GMED) by Rhoads Ann D
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-11-07 | GMED | Sale | 8,000 | 81.00 | 648,000 |
| 2025-11-10 | GMED | Sale | 2,000 | 85.00 | 170,000 |
| 2025-09-15 | GMED | Sale | 10,000 | 58.46 | 584,600 |
| 2024-09-13 | GMED | Sale | 15,000 | 70.36 | 1,055,400 |
| 2024-09-13 | GMED | Option Ex | 35,000 | 24.81 | 868,350 |
| 2023-01-27 | GMED | Option Ex | 7,500 | 12.59 | 94,425 |
| 2021-03-01 | GMED | Option Ex | 15,384 | 10.66 | 163,993 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Rhoads Ann D
(Director of Quidelortho Corp at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.